These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 29101123)
1. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy. Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123 [TBL] [Abstract][Full Text] [Related]
2. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy. Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344 [TBL] [Abstract][Full Text] [Related]
3. Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy. Yoon JS; Chae MK; Jang SY; Lee SY; Lee EJ Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5921-9. PubMed ID: 22871832 [TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-Phosphate Mediates Fibrosis in Orbital Fibroblasts in Graves' Orbitopathy. Ko J; Chae MK; Lee JH; Lee EJ; Yoon JS Invest Ophthalmol Vis Sci; 2017 May; 58(5):2544-2553. PubMed ID: 28492873 [TBL] [Abstract][Full Text] [Related]
5. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy. Tong BD; Xiao MY; Zeng JX; Xiong W Mol Vis; 2015; 21():324-34. PubMed ID: 25873777 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves' orbitopathy. Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS PLoS One; 2019; 14(8):e0221077. PubMed ID: 31415657 [TBL] [Abstract][Full Text] [Related]
7. Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts. Tsai CC; Wu SB; Kau HC; Wei YH Sci Rep; 2018 May; 8(1):7276. PubMed ID: 29739987 [TBL] [Abstract][Full Text] [Related]
8. Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts. Galgoczi E; Jeney F; Gazdag A; Erdei A; Katko M; Nagy DM; Ujhelyi B; Steiber Z; Gyory F; Berta E; Nagy EV J Endocrinol; 2016 May; 229(2):187-96. PubMed ID: 26979769 [TBL] [Abstract][Full Text] [Related]
9. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy. Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725 [No Abstract] [Full Text] [Related]
10. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy. Wu SB; Hou TY; Kau HC; Tsai CC Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057 [TBL] [Abstract][Full Text] [Related]
11. Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy. Jang SY; Choi SH; Kikkawa D; Lee EJ; Yoon JS PLoS One; 2021; 16(8):e0255344. PubMed ID: 34383782 [TBL] [Abstract][Full Text] [Related]
12. TGF-β1 Induces Human Tenon's Fibroblasts Fibrosis via miR-200b and Its Suppression of PTEN Signaling. Tong J; Chen F; Du W; Zhu J; Xie Z Curr Eye Res; 2019 Apr; 44(4):360-367. PubMed ID: 30512998 [TBL] [Abstract][Full Text] [Related]
13. MiR-146a reduces fibrosis after glaucoma filtration surgery in rats. Han R; Zhong H; Zhang Y; Yu H; Zhang Y; Huang S; Yang Z; Zhong Y J Transl Med; 2024 May; 22(1):440. PubMed ID: 38720358 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase. Choi YJ; Kim C; Choi EW; Lee SH; Chae MK; Jun HO; Kim BY; Yoon JS; Jang SY PLoS One; 2022; 17(8):e0270416. PubMed ID: 35980936 [TBL] [Abstract][Full Text] [Related]
15. Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy. Kim BY; Choi SH; Kim JY; Ko J; Yook JI; Kim HS; Lee EJ; Kikkawa DO; Yoon JS Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):7. PubMed ID: 35671049 [TBL] [Abstract][Full Text] [Related]
16. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy. van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339 [TBL] [Abstract][Full Text] [Related]
17. Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy. Tsai CC; Wu SB; Chang PC; Wei YH PLoS One; 2015; 10(11):e0143514. PubMed ID: 26599235 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a downregulates the production of hyaluronic acid and collagen I in Graves' ophthalmopathy orbital fibroblasts. Liu W; Ma C; Li HY; Chen L; Yuan SS; Li KJ Exp Ther Med; 2020 Nov; 20(5):38. PubMed ID: 32952629 [TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients. Ekronarongchai S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S Thyroid; 2021 Oct; 31(10):1566-1576. PubMed ID: 34235979 [No Abstract] [Full Text] [Related]
20. Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model. Byeon HJ; Kim JY; Ko J; Lee EJ; Don K; Yoon JS PLoS One; 2020; 15(8):e0237015. PubMed ID: 32760098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]